BR Biopharma, Inc. (NASDAQ:BRBI) Plans $0.15 Quarterly Dividend

BR Biopharma, Inc. (NASDAQ:BRBI) declared a quarterly dividend on Friday, May 8th. Stockholders of record on Tuesday, May 19th will be paid a dividend of 0.147 per share on Friday, June 5th. This represents a c) dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date is Tuesday, May 19th.

BR Biopharma Price Performance

Shares of BRBI stock opened at $14.41 on Friday. BR Biopharma has a 52-week low of $12.15 and a 52-week high of $67.01. The business’s 50 day simple moving average is $14.80.

BR Biopharma (NASDAQ:BRBI) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $25.95 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings assumed coverage on BR Biopharma in a research note on Friday, February 13th. They set a “sell (e-)” rating for the company. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.